Skip to main content
. Author manuscript; available in PMC: 2013 Oct 28.
Published in final edited form as: Cancer Gene Ther. 2012 Nov 9;20(1):17–24. doi: 10.1038/cgt.2012.75

Figure 1.

Figure 1

Cytotoxic effects of MDA’s. (A) HUVEC (human umbilical vein endothelial cells) primary cultures and endothelial cell lines MS1 (mouse pancreatic), C166 (mouse yolk sac), HBME-1 (human bone marrow) and (B) Human CWR22 and PC3 prostate cancer cell lines were treated with increasing concentrations of the indicated MDA’s. MTS assays were performed on day 3 to determine the extent of cell killing.